Expression of EphA2 in Human Astrocytic Tumors: Correlation with Pathologic Grade, Proliferation and Apoptosis

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Tumor Biology

• Publication date

  2007-05-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000103010PMID 17519535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of EphA2 and Ephrin A-1 in Carcinoma of the Urinary Bladder

  2006cited by this paper
• EphA2 as a target for ovarian cancer therapy

  2005cited by this paper
• Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma.

  2005cited by this paper
• EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme

  2005cited by this paper
• The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.

  2005cited by this paper
• Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma.

  2005cited by this paper
• EphA2 as a glioma-associated antigen: a novel target for glioma vaccines.

  2005cited by this paper
• Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.

  2005cited by this paper
• A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis

  2005cited by this paper
• EPHA2/EFNA1 expression in human gastric cancer

  2005cited by this paper
• EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma

  2004cited by this paper
• Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1

  2004cited by this paper
• EphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma

  2004cited by this paper
• Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness.

  2004cited by this paper
• Correlation of EPHA2 overexpression with high microvessel count in human primary colorectal cancer

  2004cited by this paper
• The role of ephrins and Eph receptors in cancer.

  2004cited by this paper
• Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly.

  2004cited by this paper
• Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.

  2003cited by this paper
• Multiple roles of ephrins in morphogenesis, neuronal networking, and brain function.

  2003cited by this paper
• Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo

  2002cited by this paper
• EphA2 overexpression causes tumorigenesis of mammary epithelial cells.

  2001cited by this paper
• Up‐regulation of ephrin‐a1 during melanoma progression

  1999cited by this paper
• Overexpression of the EphA2 tyrosine kinase in prostate cancer

  1999cited by this paper
• Malignancies of the Uterine Corpus and Immunoreactivity Score of the DNA “Mismatch-Repair” Enzyme Human Mut-S-Homologon-2

  1999cited by this paper
• Protein tyrosine kinases and cancer.

  1997cited by this paper

• Multi-receptor targeted therapy of breast cancer and brain metastases with a novel QUAD-drug conjugate

  2025cites this paper
• Evolving CAR T-Cell Therapy to Overcome the Barriers in Treating Pediatric Central Nervous System Tumors.

  2025cites this paper
• Aptamers: ushering in new hopes in targeted glioblastoma therapy

  2024cites this paper
• Radiomics-based MRI for predicting Erythropoietin-producing hepatocellular receptor A2 expression and tumor grade in brain diffuse gliomas

  2021cites this paper
• to in

  2020cites this paper
• The Role of RNA and DNA Aptamers in Glioblastoma Diagnosis and Therapy: A Systematic Review of the Literature

  2020cites this paper
• EphA2 contributes to disruption of the blood-brain barrier in cerebral malaria

  2020cites this paper
• Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers

  2018cites this paper
• Quo Vadis—Do Immunotherapies Have a Role in Glioblastoma?

  2018cites this paper
• Chimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome them

  2017cites this paper
• Updates On Chimeric Antigen Receptor-Mediated Glioblastoma Immunotherapy.

  2017cites this paper
• Enhancing Irreversible Electroporation by Manipulating Cellular Biophysics with a Molecular Adjuvant.

  2017cites this paper
• Investigating the Applications of Electroporation Therapy for Targeted Treatment of Glioblastoma Multiforme Based on Malignant Properties of Cells

  2017cites this paper
• Chimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome them

  2016cites this paper
• Proteolytic regulation of the EphB4-Ephrin-B2 signalling axis in prostate cancer

  2016cites this paper
• EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control System

  2015cites this paper
• MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression

  2014cites this paper
• Eph receptors as therapeutic targets in glioblastoma

  2014cites this paper
• Ephs and Ephrins in malignant gliomas

  2014cites this paper
• Increased EphB2 expression predicts cholangiocarcinoma metastasis

  2014cites this paper
• Eph receptors and their ligands: promising molecular biomarkers and therapeutic targets in prostate cancer.

  2013cites this paper
• Structural and Functional Characterization of Monomeric EphrinA1 Binding Site to EphA2 Receptor*

  2012cites this paper
• Emerging strategies for EphA2 receptor targeting for cancer therapeutics

  2011cites this paper
• Role of MicroRNA-26b in Glioma Development and Its Mediated Regulation on EphA2

  2011cites this paper
• Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System

  2011cites this paper
• Clinical Significance of Ephrin (Eph)-A1, -A2, -A4, -A5 and -A7 Receptors in Pancreatic Ductal Adenocarcinoma

  2010cites this paper
• Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma

  2010cites this paper
• RNA interference targeting EphA 2 inhibits proliferation , induces apoptosis , and cooperates with cytotoxic drugs in human glioma cells

  2009cites this paper
• RNA interference targeting EphA2 inhibits proliferation, induces apoptosis, and cooperates with cytotoxic drugs in human glioma cells.

  2008cites this paper
• RNAi-mediated inhibition of MSP58 decreases tumour growth, migration and invasion in a human glioma cell line

  2008cites this paper
• Expression of Kir 4.1 in human astrocytic tumors: correlation with pathologic grade.

  2008cites this paper